{"disease":{"id":"pyrexia","name":"pyrexia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03399318","title":"Aggressive Antipyretics for Fever Reduction in CNS Malaria","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":256,"lead_sponsor_name":"University of Rochester","has_results":true},{"nct_id":"NCT04397380","title":"COVID-19 Thales Thermography Triage : Thermal Camera Feasibility Study","phase":"","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"NHS Greater Clyde and Glasgow","has_results":false},{"nct_id":"NCT04652258","title":"Pyrexia Management Using an IL-6 Antibody in BRAF+ Melanoma Patients Treated with Dabrafenib/ Trametinib +/- Immunotherapy","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":20,"lead_sponsor_name":"University of Zurich","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}